Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals

被引:19
作者
Anthony, D. D. [1 ]
Umbleja, T. [2 ]
Aberg, J. A. [3 ]
Kang, M.
Medvik, K. [1 ]
Lederman, M. M. [1 ]
Peters, M. G. [4 ]
Koziel, M. J. [5 ]
Overton, E. T. [6 ]
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] NYU, New York, NY USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Washington Univ, St Louis, MO USA
关键词
Cellular immunity; Vaccine; Hepatitis B; Monocyte; Progenitor cell; Human; COLONY-STIMULATING FACTOR; HEPATITIS-A VACCINE; HUMAN-IMMUNODEFICIENCY-VIRUS; FACTOR GM-CSF; T-CELLS; B-VACCINE; HEMODIALYSIS-PATIENTS; IMMUNE SUPPRESSION; DENDRITIC CELLS; CANCER-PATIENTS;
D O I
10.1016/j.vaccine.2011.02.092
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated immunologic predictors of response to HBV vaccine administered in the presence or absence of GM-CSF in HIV infected individuals. We measured peripheral blood hematopoietic progenitor, monocyte and myeloid-derived suppressor cell (MDSC) frequencies, and expression of GMCSF receptor on monocytes and MDSCs, at baseline and 4 weeks after immunization in relation to antibody response. We observed higher baseline progenitor and lower monocyte frequencies among week 16 antibody responders. Week 4 decline in MDSC frequency was associated with week 16 antibody response, while administration of GM-CSF was associated with preservation of these cells. No significant differences in GM-CSF receptor expression were observed in the presence vs. absence of GM-CSF. These findings are consistent with a positive role of progenitor cells and a potential negative role of monocytes in vaccine response. Additionally, GM-CSF augmented the preservation of peripheral blood MDSC, which may contribute to the lack of improved vaccine responses. Published by Elsevier Ltd.
引用
收藏
页码:3558 / 3563
页数:6
相关论文
共 25 条
[1]   Overview of vaccines [J].
Ada, G .
MOLECULAR BIOTECHNOLOGY, 1997, 8 (02) :123-134
[2]  
Blom B, 1997, J IMMUNOL, V158, P3571
[3]   Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection [J].
das Graças Sasaki, M ;
Foccacia, R ;
de Messias-Reason, IJ .
VACCINE, 2003, 21 (31) :4545-4549
[4]   THE CELLULAR BASIS FOR LACK OF ANTIBODY-RESPONSE TO HEPATITIS-B VACCINE IN HUMANS [J].
EGEA, E ;
IGLESIAS, A ;
SALAZAR, M ;
MORIMOTO, C ;
KRUSKALL, MS ;
AWDEH, Z ;
SCHLOSSMAN, SF ;
ALPER, CA ;
YUNIS, EJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :531-538
[5]   Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine [J].
Filipazzi, Paola ;
Valenti, Roberta ;
Huber, Veronica ;
Pilla, Lorenzo ;
Canese, Paola ;
Iero, Manuela ;
Castelli, Chiara ;
Mariani, Luigi ;
Parmiani, Giorgio ;
Rivoltini, Licia .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) :2546-2553
[6]   Myeloid-derived suppressor cells as regulators of the immune system [J].
Gabrilovich, Dmitry I. ;
Nagaraj, Srinivas .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (03) :162-174
[7]   IMMUNOGENICITY AND SAFETY OF AN INACTIVATED HEPATITIS-A VACCINE IN ANTI-HIV POSITIVE AND NEGATIVE HOMOSEXUAL MEN [J].
HESS, G ;
CLEMENS, R ;
BIENZLE, U ;
SCHONFELD, C ;
SCHUNCK, B ;
BOCK, HL .
JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (01) :40-42
[8]   Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications [J].
Hilleman, MR .
VACCINE, 2001, 19 (15-16) :1837-1848
[9]   Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders [J].
Jha, R ;
Lakhtakia, S ;
Jaleel, MA ;
Narayan, G ;
Hernlatha, K .
RENAL FAILURE, 2001, 23 (05) :629-636
[10]   Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients [J].
Kapoor, D ;
Aggarwal, SR ;
Singh, NP ;
Thakur, V ;
Sarin, SK .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (05) :405-409